Financials
- Market Capitalization 836.85 M
- Employee 29
- Founded 2018
- CEO N/A
- Website www.climbbio.com
- Headquarter Delaware, United States
- FIGI BBG00ZNKL0K6
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.55
市销率
-932.13
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2529 | TBPH Theravance Biopharma, Inc. - Ordinary Shares | 17.05 USD | +0.06% | +0.35% | +1.01% | +18.82% | 885.21 M USD | ||
| 2551 | RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 46.48 USD | -0.81% | +1.86% | +20.48% | +54.26% | 868.24 M USD | ||
| 2583 | ACHV Achieve Life Sciences, Inc. - Common Shares | 8.10 USD | -0.98% | +1.50% | +29.81% | +175.51% | 833.51 M USD | ||
| 2597 | PHAR Pharming Group N.V. - ADS, each representing 10 | 11.70 USD | -1.27% | +0.69% | -8.31% | -21.90% | 820.97 M USD |